For example, the combination of NLRC3 inhibitors with PD-1/PD-L1 inhibitors has been shown to not only suppress tumor growth but also to increase T cell infiltration and activity within the tumor microenvironment, underscoring the potent anti-tumor effects of this combinatorial approach 113. Here, NLRC3 is linked to neoplasm.